Skip to main content
MustGrow Biologics Corp. logo

MustGrow Biologics Corp. — Investor Relations & Filings

Ticker · MGRO LEI · 9845005BD07663ADDF76 TSXV Manufacturing
Open in API
Filings indexed 164 across all filing types
Latest filing 2026-04-24 Regulatory Filings
Country CA Canada
Listing TSXV MGRO

About MustGrow Biologics Corp.

https://mustgrow.ca/

MustGrow Biologics Corp. is an agricultural biotechnology company focused on the development and commercialization of innovative biological and regenerative agriculture solutions. The company provides sustainable, natural alternatives to synthetic chemicals, including biopesticides, biostimulants, and biofertility products designed to enhance crop health and soil resilience. MustGrow's core proprietary technology is derived from the mustard plant, utilizing its compounds for soil biocontrol against pests and diseases, and for biofertility, exemplified by the product TerraSante™. Commercialization efforts include North American distribution via its NexusBioAg division and global strategic partnerships, notably an exclusive commercial licensing agreement with Bayer for preplant biocontrol technologies across Europe, the Middle East, and Africa.

Recent filings

Filing Released Lang Actions
Notice of the meeting and record date - English.pdf
Regulatory Filings Classification · 1% confidence The document is a formal notice filed with Canadian securities regulators by Computershare, advising of the upcoming annual general and special meeting of MustGrow Biologics Corp., including record dates, meeting date, location, and notice‐and‐access details. It does not include proxy materials themselves or voting results, nor is it the full proxy statement or AGM materials. It is a regulatory notice that does not fit more specific categories such as a proxy statement (PSI) or voting results (DVA). Therefore it falls under the fallback category for miscellaneous regulatory filings (RNS).
2026-04-24 English
Notice of the meeting and record date - English.pdf
Regulatory Filings Classification · 1% confidence The document is a formal notification to Canadian securities regulators concerning an upcoming Annual General and Special Meeting for Mustgrow Biologics Corp. It details meeting dates, record dates, proxy distribution logistics, and voting security specifics. It does not include the actual proxy materials or information statement, nor is it reporting voting results or financial results. As it does not fit any specific category like AGM presentations, proxy statements, or dividend notices, it falls into the general regulatory announcement bucket.
2026-04-24 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a corporate press release announcing the closure of a distribution arm and a shift in operational focus, with only secondary mention of recent equity and credit financings. It is not an earnings release, regulatory audit, capital markets prospectus, or any specific report type. It does not fit categories like M&A, dividend notice, director dealings, or interim/annual report. As a general corporate announcement, it falls under the fallback category for miscellaneous regulatory filings.
2026-04-08 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a press release issued by MustGrow Biologics Corp. announcing the results of a 2-year field trial program for their TerraMG technology. It provides operational updates, scientific findings, and market context regarding their product development. It does not constitute a formal financial report (10-K, IR), a transcript, or a governance document. As it is a general corporate announcement regarding business operations and product development, it falls under the 'Regulatory Filings' (RNS) category as the appropriate fallback for miscellaneous corporate news releases.
2026-02-03 English
Report of exempt distribution (45-106F1).pdf
Regulatory Filings Classification · 1% confidence The document is a 'Form 45-106F1 Report of Exempt Distribution', which is a mandatory regulatory filing in Canada used to report the distribution of securities to investors under prospectus exemptions. It details the issuer (MustGrow Biologics Corp.), the distribution dates, the types of securities issued (common shares and warrants), the jurisdictions of the purchasers, and compensation paid to underwriters. This is a standard regulatory filing for capital raising activities and does not fit into categories like 'Annual Report' or 'Earnings Release'. Given the specific nature of the form as a regulatory requirement for capital distribution, it is classified as a Regulatory Filing.
2026-02-02 English
News release - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a press release announcing the closing of a non-brokered private placement (LIFE Offering) of units consisting of common shares and warrants. It details the gross proceeds, the use of funds, and the regulatory exemptions used for the offering. This falls squarely under the definition of a capital or financing update.
2026-01-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.